Multiple Sclerosis Drugs Market: Global Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2013-2017 and Forecast 2018-2024

Multiple Sclerosis Drugs Market: Global Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2013-2017 and Forecast 2018-2024

Multiple Sclerosis Drug Market is Projected to Surpass around US$ XX Mn by 2025, Due to Increased Demyelinating Disease that Affects Spinal Cord and Brain

“The Multiple Sclerosis Drug Market is anticipated to reach about US$ XX Mn by 2025, and anticipated to expand at a CAGR over seven years of forecast period 2019-2025” owing to rising prevalence of multiple sclerosis and higher treatment compliances.

Precision Business Insights (PBI) in its report titled “Multiple Sclerosis Drug Market: Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2013-2018 and Forecast 2019-2025” assesses the market performance over seven years forecast period from 2019 to 2025. The report analyses the market value forecast and provides the strategic insights into the market driving factors, challenges that are hindering the market revenue growth over forecast period.

The multiple sclerosis market has accounted for US$ XX Mn in 2018 and anticipated to account for US$ XX Mn by 2025. Increased prevalence of diseases that affects spinal cord and brain will create demand for multiple sclerosis drug market. Multiple sclerosis drug market is majorly influenced by increased number of patients from secondary progressive relapsing-remitting multiple sclerosis.

Free sample of this report is available upon request @

https://www.precisionbusinessinsights.com/market-reports/global-multiple-sclerosis-drugs-market/#ulp-h4n2eZVGqb32xpPc

Multiple sclerosis drug market segmented on the basis of mode of administration, distribution channel, and drug class

Parenteral Segment Expected to Dominate the Market

Based on route of administration, the multiple sclerosis drug market is segmented as oral and parenteral administration. Currently, parenteral MS drugs held the largest market share. The growth of this segment is mainly driven by sales of Avonex, Betaseron, Copaxone, Extavia, Glatopa, Plegridy, Rebif, Zinbryta.

North America, Accounts for Major Revenue Share for Multiple Sclerosis Drug Market

Precision Business Insights (PBI), multiple sclerosis drug market report analyses the market in different regions North America, Europe, Asia Pacific, Latin America and Middle East and Africa. According to regional analysis, North America accounted for major revenue share due to increased prevalence of multiple sclerosis diseases. In North America, U.S holds the major revenue share followed by Canada. Rising incidence, technological advances, and higher cost of treatment medication are prime factors that facilitating the growth of market in North America.

Strategic Approaches and Launching of the Product Witnessed to Stimulate the Multiple Sclerosis Drug Market

In 2015, Bayer Healthcare Pharmaceuticals Inc. launched betaconnect, the first electric auto injector to treat of multiple sclerosis. In March 2017, U.S. FDA approved ocrevus (Genetech USA,Inc.) to treat adult patients with relapsing form of multiple sclerosis and primary progression multiple sclerosis(PPMS).And this is first to treat this type of Multiple Sclerosis.

Key market players in multiple sclerosis drug market include Novartis AG (Switzerland), Teva Pharmaceutical industries Ltd. (Israel), Biogen, Inc. (U.S.), Merck & Co., Inc. (U.S.), Sanofi S.A. (France), Acorda Therapeuitics (U.S.), Pfizer Inc. (U.S.), Bayer AG (Germany) and Medtronic plc (Questcor Pharmaceuiticals) (U.S.) to name a few.

Free TOC of this report is available upon request @

https://www.precisionbusinessinsights.com/market-reports/global-multiple-sclerosis-drugs-market/#ulp-4H8Z4LpNMLEuOnnx

Detailed Segmentation

By Route of Administration

o Oral
o Parenteral

By Distribution Channel Type

o Hospital Pharmacy
o Retail Pharmacy
o Online Pharmacy

By Drug Class Type

o Disease Modifying Drugs (DMDs)
o Steroids
o Others

Geography

o North America
 U.S.
 Canada
o Europe
 Germany
 UK
 France
 Russia
 Spain
 Italy
 Rest of Europe
o Asia-Pacific
 China
 Japan
 India
 ASEAN
 Rest of Asia Pacific
o Latin America
 Brazil
 Mexico
 Argentina
 Chile
 Rest of Latin America
o Middle East and Africa
 South Africa
 Saudi Arabia
 Rest of MEA

Get access to full summary @
https://www.precisionbusinessinsights.com/market-reports/global-multiple-sclerosis-drugs-market/

Precision Business Insights is one of the leading market research and business consulting firm, which follow a holistic approach to solve needs of the clients. We adopt and implement proven researchmethodologies to achieve better results. We help our clients by providing actionable insights and strategies to make better decisions. We provide consulting, syndicated and customised market research services based on our client needs.

Precision Business Insights mission is to provide high-quality market research reports and generate key insights to our clients. PBI’s approachable strategies are to help clients to make key decisions for business growth.

Precision Business Insights vision is to become most valued partner to fortune 500 companies by providing agile, accurate, and actionable market insights

Kemp House,

152 – 160 City Road,

London EC1V 2NX

Email: sales@precisionbusinessinsights.com

Toll Free (US): +1-866-598-1553
Website @ www.precisionbusinessinsights.com

This release was published on openPR.